Justin Dye - 17 Nov 2022 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Daniel R. Pabon, Attorney-in-Fact for Justin Dye
Issuer symbol
SHWZ
Transactions as of
17 Nov 2022
Transactions value $
$667,373
Form type
4
Filing time
21 Nov 2022, 20:31:04 UTC
Previous filing
15 Feb 2024
Next filing
25 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHWZ Common Stock Award $45,218 +26,290 +5.5% $1.72 504,742 17 Nov 2022 Direct F1
transaction SHWZ Common Stock Award $303,654 +178,620 +35% $1.7 683,362 18 Nov 2022 Direct F2
transaction SHWZ Common Stock Award $318,500 +175,000 +26% $1.82 858,362 21 Nov 2022 Direct F3
holding SHWZ Common Stock 9,287,500 17 Nov 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.78 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.81 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.78 to $1.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.